InsidersTradesSigma
Track the ALK-Abelló stock price and the full management transaction log of the company, a listed equity based in Denmark. Shares are quoted on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, ALK-Abelló has recorded 89 public disclosures. Market capitalisation: €49.2bn. The latest transaction was filed on 1 June 2026 (Other). All data is accessible without an account.
89
Insider Decl.
n/a
Thresholds
€26bn
25 ops.
Buy Volume
€15bn
12 ops.
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,668 of 29,053 companies
63.3
score / 100
Value41
Quality85
FCF yld3.1%
Earn yld2.6%
EV/EBITDA23.4x
ROE21%
Gross mgn67%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 June 2026
Declarations89 total
00ShareOutside a market placeISIN DK0061802139DK:1445832
152.66 shares0ShareOutside a market placeISIN DK0061802139DK:1346969
1,606 shares@ DKK 155.680.0001% mcap0.0% of flowShareNASDAQ CopenhagenISIN DK0061802139DK:1344674
35,535 shares@ DKK 75.720.0007% mcap0.0% of flowShareOutside a market placeISIN DK0061802139DK:1313156
1,880 shares@ DKK 132.600.0001% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0061802139DK:1279324
130 shares0ShareOutside a market placeISIN DK0061802139DK:1279059
8,400 shares@ DKK 130.9240.0003% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0061802139DK:1274257
70,000 shares@ DKK 59.160.0010% mcap0.0% of flowShareOutside a market placeISIN DK0061802139DK:1274175
103 shares0ShareOutside a market placeISIN DK0061802139DK:1210885
1,834 shares@ DKK 108.200.0000% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0061802139DK:1205683
50,000 shares@ DKK 144.700.0018% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0061802139DK:1177638
201,760 shares@ DKK 57.720.0028% mcap0.0% of flowShareOutside a market placeISIN DK0061802139DK:1175790
84,000 shares@ DKK 128.660.0026% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0061802139DK:1162652
86,692 shares@ DKK 41.120.0009% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0061802139DK:1162045
2,515 shares0ShareNASDAQ CopenhagenISIN DK0060027142DK:1143949
6,514 shares@ DKK 3,090.520.0049% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1127037
1,050.83 shares@ DKK 866.290.0002% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1126582
7,736 shares@ DKK 802.280.0015% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1125266
201 shares@ DKK 2,962.000.0001% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1110103
450 shares@ DKK 2,726.000.0003% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1030972
2,619 shares@ DKK 2,425.000.0015% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1009110
5,000 shares@ DKK 2,600.000.0032% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1008042
3,200 shares@ DKK 2,621.000.0020% mcap0.0% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1007813
2,639 shares0ShareNasdaq CopenhagenISIN DK0060027142DK:1007812
17,068 shares5.9% of flowShareNasdaq CopenhagenISIN DK0060027142DK:1006475
25 of 89 declarations
About ALK-Abelló
ALK-Abelló is a company focused on developing treatments for allergies, particularly immunotherapies. It is listed on the XCSE exchange.